abstract |
The present invention relates to compounds of formula (I) useful for treating Alzheimer's disease and other similar diseases. Such compounds include β-secretase enzyme inhibitors useful in treating Alzheimer's disease in mammals and other diseases characterized by Aβ peptide deposition. The compounds of the present invention are useful in pharmaceutical compositions and methods of treatment that reduce the production of Aβ peptide. |